University of California San Francisco
Give to UCSF
A clinical trial of new treatment regimens, led in part by researchers at UCSF, recently demonstrated that a more potent combination of antibiotics could shorten the duration of treatment for TB.
UCSF researchers have leveraged two new molecules, one of which is currently in clinical oncology trials, to devise a dual-drug therapy for alcohol use disorder (AUD), without the side effects or complications associated with current treatment regimens.
UCSF researchers in collaboration with the Centers for Disease Control’s Tuberculosis Trials Consortium and the AIDS Clinical Trials Group published a landmark study that demonstrated a new four-month treatment regimen for tuberculosis was safe and as efficacious as the standard six-month therapy.
A UCSF study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription of the antibiotic for the disease.
This long-delayed treatment milestone might not have happened at all without seminal accomplishments by UCSF chemist Kevan Shokat, who succeeded in revitalizing a holy-grail-like quest after almost all others had given up.
T cells – immune cells that patrol our bodies in search of trouble – have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells
After more than four decades at UCSF, B. Joseph Guglielmo, PharmD, dean of the UCSF School of Pharmacy, who has led for nearly 10 years what is widely regarded as the best pharmacy school in the nation, has announced that he will retire December 31, 2021.
The viruses that cause polio and COVID-19 mutate, but treatments for the diseases don’t. For over 20 years, UCSF and Gladstone Institutes scientist Leor Weinberger, PhD, has been thinking of ways to make vaccines work more efficiently by being adaptive, rather than static.
Continuing medication for newborns with seizures for months after they are discharged from the hospital does not prevent epilepsy and may cause neurotoxic side effects. In a study led by UCSF
Six health care experts grapple with how to address race without being racist.
We asked UCSF infectious disease expert Monica Gandhi, MD, MPH, to unpack some of the big questions around vaccine science, such as how the Johnson & Johnson vaccine differs, how well it works against the new variants, and whether you should be worried about transmitting the virus after vaccination.
UCSF scientists have formed a research alliance with pharmaceutical firm Eli Lilly and Company aimed at better understanding autoimmune diseases and fostering the development of new therapies
We turned to UCSF scientists to better understand probiotics and the human microbiome they aim to influence.
